These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21136275)

  • 21. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
    Zaritsky J; Young B; Wang HJ; Westerman M; Olbina G; Nemeth E; Ganz T; Rivera S; Nissenson AR; Salusky IB
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1051-6. PubMed ID: 19406957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum prohepcidin levels in chronic inflammatory bowel diseases.
    Nagy J; Lakner L; Poór VS; Pandur E; Mózsik G; Miseta A; Sipos K
    J Crohns Colitis; 2010 Dec; 4(6):649-53. PubMed ID: 21122575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of and correspondence among different hepcidin forms in blood and urine and their relationships to iron status in healthy, male Guatemalan volunteers observed over 9 weeks.
    Schuemann K; Solomons NW; Laarakkers CM; Romero-Abal ME; Kroll S; Weiss G; Swinkels DW
    Ann Nutr Metab; 2011; 58(2):158-66. PubMed ID: 21654163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C.
    Ryan JD; Altamura S; Devitt E; Mullins S; Lawless MW; Muckenthaler MU; Crowe J
    Hepatology; 2012 Aug; 56(2):492-500. PubMed ID: 22334511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.
    Zaritsky J; Young B; Gales B; Wang HJ; Rastogi A; Westerman M; Nemeth E; Ganz T; Salusky IB
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1010-4. PubMed ID: 20299375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders.
    Kroot JJ; Laarakkers CM; Geurts-Moespot AJ; Grebenchtchikov N; Pickkers P; van Ede AE; Peters HP; van Dongen-Lases E; Wetzels JF; Sweep FC; Tjalsma H; Swinkels DW
    Clin Chem; 2010 Oct; 56(10):1570-9. PubMed ID: 20739637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prokaryotic Expression of Hepatitis C Virus-NS3 Protein and Preparation of a Monoclonal Antibody.
    Xi Y; Zhang Y; Fang J; Whittaker K; Luo S; Huang RP
    Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):251-258. PubMed ID: 29267148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women.
    Young MF; Glahn RP; Ariza-Nieto M; Inglis J; Olbina G; Westerman M; O'Brien KO
    Am J Clin Nutr; 2009 Feb; 89(2):533-8. PubMed ID: 19073788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice.
    Viatte L; Nicolas G; Lou DQ; Bennoun M; Lesbordes-Brion JC; Canonne-Hergaux F; Schönig K; Bujard H; Kahn A; Andrews NC; Vaulont S
    Blood; 2006 Apr; 107(7):2952-8. PubMed ID: 16339398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.
    Lainé F; Laviolle B; Ropert M; Bouguen G; Morcet J; Hamon C; Massart C; Westermann M; Deugnier Y; Loréal O
    Eur J Appl Physiol; 2012 Apr; 112(4):1391-7. PubMed ID: 21818622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload.
    Floreani A; Navaglia F; Rizzotto ER; Basso D; Chiaramonte M; Padoan A; Petridis I; Cazzagon N; Testa R; Marra M; Plebani M
    Clin Chem Lab Med; 2011 Feb; 49(2):197-206. PubMed ID: 21143008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice.
    Gao J; Chen J; De Domenico I; Koeller DM; Harding CO; Fleming RE; Koeberl DD; Enns CA
    Blood; 2010 Apr; 115(16):3374-81. PubMed ID: 20177050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration.
    Troutt JS; Rudling M; Persson L; Ståhle L; Angelin B; Butterfield AM; Schade AE; Cao G; Konrad RJ
    Clin Chem; 2012 Aug; 58(8):1225-32. PubMed ID: 22679180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women.
    Huang X; Fung ET; Yip C; Zeleniuch-Jacquotte A
    Blood Cells Mol Dis; 2008; 41(3):265-9. PubMed ID: 18694648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-sensitive radioimmunoassay for human serum hepcidin.
    Grebenchtchikov N; Geurts-Moespot AJ; Kroot JJ; den Heijer M; Tjalsma H; Swinkels DW; Sweep FG
    Br J Haematol; 2009 Aug; 146(3):317-25. PubMed ID: 19500086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry.
    Murphy AT; Witcher DR; Luan P; Wroblewski VJ
    Blood; 2007 Aug; 110(3):1048-54. PubMed ID: 17435114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
    van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
    Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible relationship between neutrophil gelatinase-associated lipocalin, hepcidin, and inflammation in haemodialysed patients.
    Malyszko J; Malyszko JS; Kozminski P; Koc-Zorawska E; Mysliwiec M; Macdougall I
    Nephron Clin Pract; 2010; 115(4):c268-75. PubMed ID: 20424477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
    Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist.
    van Deuren M; Kroot JJ; Swinkels DW
    Haematologica; 2009 Sep; 94(9):1297-300. PubMed ID: 19608676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.